Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $2.44 million. The enterprise value is -$5.73 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 4.34 million shares outstanding. The number of shares has increased by 877.24% in one year.
| Current Share Class | 4.34M |
| Shares Outstanding | 4.34M |
| Shares Change (YoY) | +877.24% |
| Shares Change (QoQ) | +171.27% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 5.75% |
| Float | 4.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.29 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.64, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.64 |
| Quick Ratio | 4.73 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.91 |
Financial Efficiency
Return on equity (ROE) is -243.94% and return on invested capital (ROIC) is -135.68%.
| Return on Equity (ROE) | -243.94% |
| Return on Assets (ROA) | -101.41% |
| Return on Invested Capital (ROIC) | -135.68% |
| Return on Capital Employed (ROCE) | -113.05% |
| Weighted Average Cost of Capital (WACC) | 33.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.28M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -136,910 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.17% in the last 52 weeks. The beta is 1.21, so Oragenics's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -91.17% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 35.80 |
| Average Volume (20 Days) | 280,201 |
Short Selling Information
The latest short interest is 792,779, so 18.28% of the outstanding shares have been sold short.
| Short Interest | 792,779 |
| Short Previous Month | 458,764 |
| Short % of Shares Out | 18.28% |
| Short % of Float | 18.71% |
| Short Ratio (days to cover) | 1.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.39M |
| Operating Income | -9.36M |
| Pretax Income | -9.98M |
| Net Income | -9.84M |
| EBITDA | n/a |
| EBIT | -9.36M |
| Earnings Per Share (EPS) | -$4.56 |
Full Income StatementBalance Sheet
The company has $8.40 million in cash and $227,348 in debt, with a net cash position of $8.17 million or $1.88 per share.
| Cash & Cash Equivalents | 8.40M |
| Total Debt | 227,348 |
| Net Cash | 8.17M |
| Net Cash Per Share | $1.88 |
| Equity (Book Value) | 8.28M |
| Book Value Per Share | 1.94 |
| Working Capital | 8.28M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.25M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -872,617 |
| Free Cash Flow | -9.25M |
| FCF Per Share | -$2.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
